Fox Chase Cancer Center News

PHILADELPHIA (February 7, 2023)—Cihangir Duy, PhD, MS, an assistant professor in the Nuclear Dynamics and Cancer research program and a member of the Cancer Epigenetics Institute at Fox Chase Cancer Center, has been awarded an American Society of Hematology (ASH) 2023 Junior Faculty Scholar Award in basic/translational research.

PHILADELPHIA (February 3, 2023)—Jaye Gardiner, PhD, a postdoctoral researcher at Fox Chase Cancer Center, has received the Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00) award from the National Institute of General Medical Sciences. She will receive up to two years of postdoctoral funding, followed by three years of funding after she secures a full-time faculty position.

PHILADELPHIA (February 2, 2023)—Protective clothing and other safeguards for those who work with asbestos have significantly reduced deaths from mesothelioma over the past decades. But what if it was also possible to protect people at high risk from the inside out? That’s the goal of a recent study at Fox Chase Cancer Center looking at a new drug candidate intended to delay or prevent the onset of mesothelioma, a rare form of cancer, after asbestos exposure.

PHILADELPHIA (January 31, 2023)—Fox Chase Cancer Center has been awarded Gold Certification for Excellence in Person-Centered Care by Planetree International, which recognizes Fox Chase’s achievement and innovation in the delivery of person-centered care. Fox Chase is one of only 98 healthcare organizations worldwide to earn this prestigious award, and only one of four organizations that focus on cancer care to be honored.

PHILADELPHIA (January 23, 2023)—Fox Chase Cancer Center has achieved Magnet designation for nursing excellence from the American Nurses Credentialing Center (ANCC) for the sixth consecutive time. Fox Chase has held Magnet status continuously since 2000, when it became the first hospital in Pennsylvania and the first specialty hospital in the United States to achieve Magnet designation.

PHILADELPHIA (January 23, 2023)—Pedro Torres-Ayuso, PhD, an assistant professor in the Department of Cancer and Cellular Biology at the Lewis Katz School of Medicine at Temple University and the Cancer Signaling and Microenvironment research program at Fox Chase Cancer Center, recently received a grant that will be incorporated into the prestigious Specialized Program of Research Excellence (SPORE) for head and neck cancer held by Fox Chase Cancer Center. 

PHILADELPHIA (January 18, 2023)—Joel Helmke, MSHP, FACHE, chief operating officer of Fox Chase Cancer Center, has been named Vice Chair of the Board of Directors of the Alliance of Dedicated Cancer Centers (ADCC). The trade association represents 10 of the nation’s leading cancer hospitals, including Fox Chase.

PHILADELPHIA (January 17, 2023)—Fox Chase Cancer Center has successfully renewed its accreditation with the National Accreditation Program for Breast Centers (NAPBC), making it the fifth consecutive time Fox Chase has received accreditation.